Search
Differential network analysis of allergen-induced CD4 T cell responses can unmask covert disease-associated genes and pin point novel therapeutic targets
Repeated video instruction over time improves inhaler technique in young children
This article looks at the clinical implications of the research into microbial exposure & protection against asthma.
The purpose of this article is to highlight emerging evidence for existing allergy prevention guidelines regarding potential benefits of supporting early...
The airway epithelium of both children and adults with asthma is relatively undifferentiated characterized by a significantly increased proportion of...
This study evaluated the relationship between cat allergen–specific biomarkers in adults with cat allergy with and without cat ownership.
Australian scientists have today launched a world first research trial into a treatment that could prevent asthma in high risk children.
Two Australian scientists are spearheading an international campaign that's challenging the way asthma drugs are developed and tested.
Ingrid Pat Laing Holt BSc PhD PhD, DSc, FRCPath, FRCPI, FAA Head, Children's Respiratory Science Emeritus Honorary Researcher 6319 1828 Ingrid.laing@
Wheezing and asthma exacerbations are leading causes of pediatric hospital admissions. Predicting which children will experience persistent exacerbations remains challenging. Prior research has identified immune endotypes in the nasal epithelium of children with acute asthma and wheezing, characterized by varying balances of interferons and inflammatory markers. Notably, children exhibiting low interferon responses coupled with high inflammation are at an increased risk for recurrent respiratory exacerbations.